药物侵入策略与直接PCI治疗STEMI的远期结局比较
该单中心回顾性研究纳入2003至2014年2091例STEMI患者,比较药物侵入PCI(PI-PCI)与及时或延迟直接PCI的3年死亡结局。结果显示延迟直接PCI死亡率高于药物侵入策略,倾向匹配后延迟直接PCI较计划PCI死亡风险比为2.2。
要点
- 延迟直接PCI的3年死亡率高于药物侵入策略。
- 计划PCI的3年死亡率低于延迟直接PCI。
- 当预计PCI延迟时,应考虑药物侵入策略。
核心结论
- 接受延迟直接PCI的患者死亡率高于接受药物侵入策略的患者。
- 尽管三分之一患者需要补救PCI,药物侵入策略仍应视为PCI延迟时的选择。
研究设计与样本
- 单中心回顾性研究,纳入2003年10月至2014年3月在利物浦医院因STEMI住院并接受PCI的患者。
- 共2091例STEMI患者(80%男性),其中1077例(52%)接受直接PCI(68%及时,32%延迟),1014例(48%)接受药物侵入PCI(33%补救,67%计划)。
主要发现
- 3年死亡率:直接PCI为11.1%(及时6.7%,延迟20.2%),药物侵入PCI为6.2%(补救9.4%,计划4.8%),P<0.01。
- 倾向匹配后,及时直接PCI较计划PCI的调整死亡风险比为0.9(95%CI 0.4-2.0),较补救PCI为0.5(95%CI 0.2-0.9)。
- 倾向匹配后,延迟直接PCI较计划PCI的调整死亡风险比为2.2(95%CI 1.2-3.1),较补救PCI为1.5(95%CI 0.7-2.0)。
临床怎么用
- 当预计直接PCI延迟时,可考虑药物侵入策略以改善远期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Pharmaco-invasive percutaneous coronary intervention (PI-PCI) is recommended for patients with ST-elevation myocardial infarction (STEMI)who are unable to undergo timely primary PCI (pPCI). The present study examined late outcomes after PI-PCI (successful reperfusion followed by scheduled PCI or failed reperfusion and rescue PCI)compared with timely and late pPCI (>120 min from first medical contact). METHODS AND RESULTS: All patients with STEMI presenting within 12 h of symptom onset, who underwent PCI during their initial hospitalization at Liverpool Hospital (Sydney), from October 2003 to March 2014, were included. Amongst 2091 STEMI patients (80% male), 1077 (52%)underwent pPCI (68% timely, 32% late), and 1014 (48%)received PI-PCI (33% rescue, 67% scheduled). Mortality at 3 years was 11.1% after pPCI (6.7% timely, 20.2% late) and 6.2% after PI-PCI (9.4% rescue, 4.8% scheduled); P < 0.01. After propensity matching, the adjusted mortality hazard ratio (HR) for timely pPCI compared with scheduled PCI was 0.9 (95% CIs 0.4-2.0) and compared with rescue PCI was 0.5 (95% CIs 0.2-0.9). The adjusted mortality HR for late pPCI, compared with scheduled PCI was 2.2 (95% CIs 1.2-3.1)and compared with rescue PCI, it was 1.5 (95% CIs 0.7-2.0). CONCLUSION: Patients who underwent late pPCI had higher mortality rates than those undergoing a pharmaco-invasive strategy. Despite rescue PCI being required in a third of patients, a pharmaco-invasive approach should be considered when delays to PCI are anticipated, as it achieves better outcomes than late pPCI.
引用
- Jamal, Idris, Faour, et al. Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention. Eur Heart J. 2023. PMID: 36459120. doi:10.1093/eurheartj/ehac661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。